Sharlene M. Day - Concepedia

Author

Sharlene M. Day

Also Known As

Day, Sharlene, Eric D. Carruth, Iacopo Olivotto, Michelle Michels, Ron Do, S M Day, S. Day, SHARLENE DAY, Sharlene Day, Sharlene M Day

258

Publications

12.1K

Citations

H-Index

Concepts

All Affiliations

University of Michigan Brigham and Women's Hospital University of Pennsylvania Boston Children's Hospital Azienda Ospedaliero-Universitaria Careggi

About

Sharlene M. Day is an author at University of Michigan specializing in medicine, cardiology, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	31	3.9K
2	Public Health	9	9	1.7K
3	Health Sciences	6	6	254
4	Engineering	1	1	110
5	Natural Sciences	1	1	42

Sharlene M. Day

Publications

9.9K

Citations

H-Index

Page 1

	Year	Citations
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary Steve R. Ommen, Seema Mital, Michael A. Burke, Journal of the American College of Cardiology CardiomyopathyStructural Heart DiseaseCardiovascular DiseaseHypertrophic CardiomyopathyCardiac Care	2020	983
Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy Carolyn Y. Ho, Sharlene M. Day, Euan A. Ashley, Circulation	2018	776
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy Steve R. Ommen, Seema Mital, Michael A. Burke, Journal of the American College of Cardiology CardiomyopathyStructural Heart DiseaseCardiovascular DiseaseHypertrophic CardiomyopathyCardiac Care	2020	651
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines Steve R. Ommen, Carolyn Y. Ho, Irfan M. Asif, Circulation	2024	494
Dystrophic heart failure blocked by membrane sealant poloxamer Soichiro Yasuda, DeWayne Townsend, Daniel E. Michele, Nature Heart FailureStructural Heart DiseasePhysiologyMembrane Sealant PoloxamerMedicine	2005	314
Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy Christopher N. Toepfer, Amanda C. Garfinkel, Gabriela Venturini, Circulation	2020	308
Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic Cardiomyopathy Barry J. Maron, Paolo Spirito, Michael J. Ackerman, Journal of the American College of Cardiology CardiomyopathyHeart FailureCardiogenic ShockCardiopulmonary ResuscitationCardiovascular Disease	2013	280
Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall Sharlene M. Day, Jennifer Reeve, Brian Pedersen, Blood	2004	279
Ubiquitin Proteasome Dysfunction in Human Hypertrophic and Dilated Cardiomyopathies Jaime M. Predmore, Ping Wang, Frank M. Davis, Circulation	2010	255
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy Steve R. Ommen, Carolyn Y. Ho, Irfan M. Asif, Journal of the American College of Cardiology CardiomyopathyCardiovascular DiseaseHypertrophic CardiomyopathyPublic HealthMedicine	2024	249

Page 1